Family stem cells tested against deadly pancreatic cancer

NCT ID NCT04087889

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tested stem cells taken from a patient's blood relative to treat pancreatic cancer, a fast-growing and often deadly disease. Only one patient was treated under a special expanded access program, which is now closed. The goal was to see if these donated stem cells could help control the cancer and improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

stem cells from a blood relative

What this could lead to

If it works, this could point toward a new way to treat pancreatic cancer using stem cells from a family member.

What could go wrong

This was a single-patient trial that is no longer available, so results are very limited. Stem cell treatments for cancer are still experimental and may not work or could cause side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenocarcinoma malignant pancreatic neoplasm neoplasm pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hope Biosciences

    Sugar Land, Texas, 77478, United States